Iduna Fichtner - Concepedia

Author

Iduna Fichtner

Also Known As

Andreas von Deimling, Anne-Sophie Govaerts, Fichtner Iduna, Fichtner, I., I FICHTNER, I Fichtner, I. FICHTNER, I. Fichtner, IDUNA FICHTNER, Iduna Fichtner

406

Publications

10.1K

Citations

H-Index

158

Concepts

All Affiliations

Max Delbrück Center Charité - Universitätsmedizin Berlin Humboldt-Universität zu Berlin Helios Hospital Berlin-Buch University College Dublin

About

Iduna Fichtner is an author at Max Delbrück Center specializing in medicine, tumor biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	39	102	5.1K
2	Health Sciences	10	11	377
3	Natural Sciences	10	10	383
4	Engineering	7	7	462
5	Public Health	1	1	70

Iduna Fichtner

173

Publications

9.6K

Citations

H-Index

Page 1

	Year	Citations
MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis Ulrike Stein, Wolfgang Walther, Franziska Arlt, Nature Medicine Tumor BiologyOncologyKey RegulatorHgf-met SignalingMedicine	2008	485
Antitumor Benzothiazoles. 3. Synthesis of 2-(4-Aminophenyl)benzothiazoles and Evaluation of Their Activities against Breast Cancer Cell Lines <i>in </i><i>Vitro </i>and <i>in Vivo</i> Dong‐Fang Shi, Tracey D. Bradshaw, Samantha Wrigley, Journal of Medicinal Chemistry	1996	364
Establishment of Patient-Derived Non–Small Cell Lung Cancer Xenografts as Models for the Identification of Predictive Biomarkers Iduna Fichtner, Jana Rolff, Richie Soong, Clinical Cancer Research	2008	282
Probing the Cysteine-34 Position of Endogenous Serum Albumin with Thiol-Binding Doxorubicin Derivatives. Improved Efficacy of an Acid-Sensitive Doxorubicin Derivative with Specific Albumin-Binding Properties Compared to That of the Parent Compound Felix Kratz, André Warnecke, Karin Scheuermann, Journal of Medicinal Chemistry	2002	271
MT110: A novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors Klaus Brischwein, Bernd Schlereth, Benjamin Guller, Molecular Immunology MedicineImmunologyAntibody EngineeringTumor TargetingImmunotherapy	2005	257
Novel Effect of Antihelminthic Niclosamide on S100A4-Mediated Metastatic Progression in Colon Cancer Ulrike Sack, Wolfgang Walther, Dominic A. Scudiero, JNCI Journal of the National Cancer Institute	2011	208
A new approach for the treatment of malignant melanoma: enhanced antitumor efficacy of an albumin-binding doxorubicin prodrug that is cleaved by matrix metalloproteinase 2. Ahmed M. Mansour, Joachim Drevs, N. Esser, PubMed ImmunologyMalignant MelanomaMatrix Metalloproteinase 2Tumor BiologyAnti-cancer Agent	2003	197
New Wnt/β-catenin target genes promote experimental metastasis and migration of colorectal cancer cells through different signals Jingjing Qi, Yong Yu, Özlem Akilli Öztürk, Gut	2015	195
T Cell Costimulus-Independent and Very Efficacious Inhibition of Tumor Growth in Mice Bearing Subcutaneous or Leukemic Human B Cell Lymphoma Xenografts by a CD19-/CD3- Bispecific Single-Chain Antibody Construct Torsten Dreier, Patrick A. Baeuerle, Iduna Fichtner, The Journal of Immunology Lymphoid NeoplasiaCancer ImmunosurveillanceTherapeutic EffectT Cell Costimulus-independentBispecific Ab	2003	194
Anticancer drug response and expression of molecular markers in early-passage xenotransplanted colon carcinomas Iduna Fichtner, W. Slisow, Jason H. Gill, European Journal of Cancer Anticancer Drug ResponseChemoprevention StrategyMolecular MarkersMedicinePharmacology	2003	153

Page 1